Officials with the Mexico Ministry of Health (MOH) have reported 8,314  dengue fever and severe dengue cases through the first week of September of this year, a decrease in cases of more than 33 percent compared to the same period in 2015 (12,559).


Mexico has seen ten dengue fatalities this year to date, for a lethality rate of 0.5 percent.

Sixty percent of cases are reported from five states–Guerrero, Veracruz, Chiapas, Jalisco and Michoacan.

In related news, vaccine manufacturer, Sanofi Pasteur announced this weekend that they would be rolling out the vaccine, Dengvaxia, in the private sector in Mexico while health authorities prepare a public immunization plan, according to an AFP report.

The company says 1 million doses of Dengvaxia are already in country.

Sanofi Pasteur’s dengue vaccine has been approved in Mexico, Brazil, El Salvador, Costa Rica,Paraguay and the Philippines.

Public vaccination against dengue began in the Philippines in April, with the goal of vaccinating 1 million fourth-grade students in over 6,000 public schools in three highly-endemic regions of the country this year. Also, Parana state in Brazil launched the first public dengue vaccination program in the Americas, targeting 500,000 people living in the most highly endemic parts of the State.